
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Corticotropin
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Details : Adrenocorticotropic Hormone is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Primary Membranous Nephropathy.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
January 25, 2023
Lead Product(s) : Corticotropin
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
